Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...

Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...

Hyderabad: Amgen, a biotechnology major from the US, is making an investment of Rs 1,600 crore in Hyderabad by 2025-end. As ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

The employees at the new Amgen campus will reach to 600 by the end of this year and is expected to provide employment to over ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...

US biopharma major Amgen is investing USD 200 million this year in its new facility here and plans to make significant investments in the coming years, the company’s CEO Robert Bradway said on Monday.